United Kingdom

Enhanc3D Genomics

2023
Speaker
Venture

Enhanc3D Genomics is a functional genomics company developing a disruptive technology capable of unlocking the 3D spatial genome for target and biomarker discovery.

The company incorporated in January 2020 and established operations at the Milner Therapeutic Institute in Cambridge, UK.

We use a selection of our own and third-party cookies on the pages of this website: Essential cookies, which are required in order to use the website; functional cookies, which provide better easy of use when using the website; performance cookies, which we use to generate aggregated data on website use and statistics; and marketing cookies, which are used to display relevant content and advertising. If you choose "ACCEPT ALL", you consent to the use of all cookies. You can accept and reject individual cookie types and revoke your consent for the future at any time at "Settings".